| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥3613.9B | ¥3311.3B | +9.1% |
| Operating Income | ¥87.4B | ¥110.7B | -21.0% |
| Ordinary Income | ¥116.5B | ¥133.5B | -12.8% |
| Net Income | ¥-11.6B | ¥17.8B | -81.9% |
| ROE | -0.4% | 0.7% | - |
FY2025 results showed divergent trends with revenue reaching 361.4 billion yen (+9.1% YoY) while operating income declined to 8.7 billion yen (-21.0% YoY). Ordinary income was 11.6 billion yen (-12.8% YoY) and the company recorded a net loss of -1.1 billion yen (versus 1.7 billion yen profit in prior year, -81.9% YoY). The revenue growth was driven by strong overseas segment performance and domestic pricing initiatives, however profitability deteriorated due to impairment losses of 3.4 billion yen primarily in the Dairy segment, increased SG&A expenses rising to 126.3 billion yen, and higher cost of goods sold. Operating cash flow improved significantly to 27.2 billion yen (+1405.5% YoY), demonstrating strong cash generation capability despite the profit decline. The company maintains guidance of 140.0 billion yen operating income for the full year, suggesting expected second-half recovery.
Revenue increased 30.2 billion yen to 361.3 billion yen, with growth across most segments. The Overseas segment led expansion with revenue of 90.7 billion yen (+10.1% YoY), contributing 25.1% of total revenue. Domestic segments showed mixed results: Dairy segment revenue grew to 66.4 billion yen (+18.5% YoY), Other Domestic business expanded to 77.2 billion yen (+14.6% YoY), and Nutritional Confectionery maintained 65.9 billion yen (+1.9% YoY). Geographic analysis reveals Japan contributed 270.6 billion yen (+8.8% YoY), while China grew substantially to 47.5 billion yen (+21.1% YoY). The gross profit margin compressed to 37.4% from prior year levels, as COGS increased 183.4 billion yen (+8.8% YoY) outpacing revenue growth rate. SG&A expenses rose 33.7 billion yen to 126.3 billion yen, with advertising expenses at 16.0 billion yen, salaries at 23.5 billion yen, and depreciation at 7.4 billion yen, resulting in SG&A ratio expansion to 35.0% of revenue.
Operating income declined 2.3 billion yen to 8.7 billion yen, with operating margin contracting 1.0pt to 2.4%. Non-operating income totaled 5.2 billion yen including equity method investment gains of 1.0 billion yen, interest income of 0.8 billion yen, and dividend income of 0.8 billion yen. Non-operating expenses of 2.3 billion yen primarily comprised foreign exchange losses of 0.8 billion yen and interest expense of 0.1 billion yen. The gap between ordinary income of 11.6 billion yen and operating income of 8.7 billion yen reflects net non-operating income contribution of 2.9 billion yen. Extraordinary items significantly impacted net results: extraordinary losses totaled 5.6 billion yen including impairment losses of 3.4 billion yen and restructuring costs of 0.5 billion yen, while extraordinary income of 2.0 billion yen included securities sales gains of 1.8 billion yen. These non-recurring factors compressed profit before tax to 8.1 billion yen, and after income tax expense of 3.0 billion yen, resulted in net loss of -1.1 billion yen. This represents a revenue up, profit down pattern, where top-line growth was achieved but profitability was severely impaired by operational margin compression, structural impairments, and elevated cost burden.
The Overseas segment is the core business generating 90.7 billion yen revenue (25.1% share) with operating income of 8.2 billion yen and margin of 9.1%, representing the highest profitability among segments. Nutritional Confectionery segment produced 65.9 billion yen revenue with operating income of 4.3 billion yen and margin of 6.6%, maintaining stable profitability. Food Ingredients segment, though smallest at 13.1 billion yen revenue, demonstrated the highest margin of 16.7% with operating income of 2.2 billion yen. The Dairy segment faced significant challenges, reporting 66.4 billion yen revenue but operating loss of -7.1 billion yen (margin -10.7%), primarily due to impairment charges of 3.3 billion yen recorded during the period. Health and Food segment similarly recorded operating loss of -1.5 billion yen (margin -3.2%) on revenue of 47.8 billion yen. Other Domestic business generated 77.2 billion yen revenue with modest operating income of 0.6 billion yen (margin 0.8%). Segment margin dispersion is material, ranging from +16.7% in Food Ingredients to -10.7% in Dairy, indicating portfolio optimization opportunities and need for structural reform in loss-making segments.
[Profitability] Operating margin was 2.4%, declining 1.0pt YoY from 3.3%, indicating profitability deterioration. Net profit margin was -0.3% compared to positive territory in prior year. ROE was -0.4%, significantly below the company's historical performance and reflecting the net loss position. The gross profit margin of 37.4% compressed from prior levels due to cost pressures outpacing pricing actions. [Cash Quality] Cash and deposits stood at 68.6 billion yen with minimal short-term debt of 0.04 billion yen, providing cash coverage ratio of 1719 times indicating extremely strong liquidity position. Operating cash flow of 27.2 billion yen was 54 times net income, demonstrating superior cash generation quality despite accounting losses. [Investment Efficiency] Total asset turnover was 0.92 times, stable from prior period. Working capital efficiency remained adequate with accounts receivable at 50.4 billion yen, inventories at 21.2 billion yen, and accounts payable at 44.2 billion yen. Capital expenditure of 10.1 billion yen represented 0.52 times depreciation and amortization of 19.6 billion yen, suggesting potential underinvestment that warrants monitoring for future growth capacity. [Financial Health] Equity ratio was 70.7%, reflecting robust capital structure. Current ratio was 189.4%, well above the safety threshold. Total interest-bearing debt was minimal at 0.15 billion yen against equity of 278.5 billion yen, resulting in negligible debt-to-equity ratio of 0.001, positioning the company with significant financial flexibility.
Operating cash flow of 27.2 billion yen represents 54 times net income, demonstrating strong cash-backed earnings quality despite the accounting loss. The operating cash flow subtotal before working capital changes was 28.6 billion yen, with working capital movements contributing positively: inventories decreased 9.3 billion yen, payables increased 5.6 billion yen, while receivables increased marginally 0.1 billion yen. Income taxes paid were 1.4 billion yen, interest and dividends received totaled 2.2 billion yen, and interest paid was minimal at 0.1 billion yen. Investing cash flow of -13.8 billion yen was primarily driven by capital expenditures of 10.1 billion yen. Financing cash flow of -7.0 billion yen reflected dividend payments with negligible share repurchases. Free cash flow of 13.4 billion yen (operating CF minus investing CF) indicates healthy cash generation capacity exceeding dividend obligations. Cash and deposits increased from prior period levels, with the strong operating cash flow more than offsetting investing and financing outflows. The operating CF to net income ratio improvement from 18.1 billion yen in prior year to 27.2 billion yen represents a 1405.5% increase, attributed to improved working capital management and non-cash charges including impairments. The cash conversion quality is high, with operating cash flow substantially exceeding reported earnings.
Ordinary income of 11.6 billion yen compared to operating income of 8.7 billion yen shows non-operating net contribution of approximately 2.9 billion yen, primarily comprising equity method gains of 1.0 billion yen, interest and dividend income totaling 1.6 billion yen, offset by foreign exchange losses of 0.8 billion yen and interest expense of 0.1 billion yen. Non-operating income represents 1.5% of revenue, indicating limited dependence on financial activities for core profitability. However, the substantial gap between ordinary income of 11.6 billion yen and net loss of -1.1 billion yen totaling 12.7 billion yen is attributable to extraordinary items: impairment losses of 3.4 billion yen concentrated in the Dairy segment, restructuring costs of 0.5 billion yen, and valuation losses on securities of 0.3 billion yen, partially offset by securities sales gains of 1.8 billion yen and asset disposal gains of 0.0 billion yen. These non-recurring factors represent significant quality concerns, as approximately 74.3% of the gap between ordinary income and net income stems from one-time items. Operating cash flow of 27.2 billion yen substantially exceeds net income, indicating healthy cash earnings quality and that accounting losses are not reflective of cash-generating capability. The accrual ratio is negative, suggesting conservative accounting practices and absence of earnings manipulation. Comprehensive income of 11.6 billion yen exceeded net income due to other comprehensive income items including foreign currency translation adjustments of 2.2 billion yen, securities valuation gains of 2.9 billion yen, and defined benefit plan remeasurements of 0.8 billion yen, indicating unrealized value creation not captured in net income.
Full-year guidance targets revenue of 380.0 billion yen (+5.1% YoY), operating income of 14.0 billion yen (+60.2% YoY), and ordinary income of 17.0 billion yen (+46.0% YoY). Current period progress rates are revenue 95.1%, operating income 62.4%, and ordinary income 68.5% of full-year targets. Given this is a full-year result versus full-year guidance comparison, the company appears to have underperformed revenue targets by 4.9% and significantly underperformed profit targets, with operating income achieving only 62.4% of guidance and ordinary income 68.5%. The substantial shortfall in profitability metrics suggests either conservative initial guidance or significant operational challenges that emerged during the year. The guidance implies expected substantial margin recovery to achieve operating income of 14.0 billion yen on revenue of 380.0 billion yen, representing 3.7% operating margin versus actual 2.4%, requiring 1.3pt margin expansion. Key assumptions from forecast notes indicate performance is subject to various factors including raw material costs, foreign exchange rates, and demand conditions, with actual results potentially varying materially. The company's ability to achieve remaining targets depends on successful implementation of pricing strategies, cost control initiatives, and resolution of Dairy segment structural issues. No order backlog data is available for forward revenue visibility assessment.
Annual dividend is 45.00 yen per share, comprising interim dividend of 22.50 yen and year-end dividend of 22.50 yen. Total dividend payments amounted to 5.7 billion yen based on outstanding shares. The dividend represents an increase from prior year levels, demonstrating commitment to shareholder returns despite profitability challenges. Payout ratio was reported at 70.6% by the company, though calculated against the reported net loss would mathematically be negative, indicating the company bases dividend policy on normalized earnings or cash flow capacity rather than reported net income. With free cash flow of 13.4 billion yen and cash reserves of 68.6 billion yen, the dividend payment is well-supported by cash generation and balance sheet strength. Share buyback activity was minimal at 0.00 billion yen during the period. Total return ratio considering both dividends and buybacks is effectively equal to the payout ratio at 70.6%, as buybacks were negligible. The dividend policy demonstrates stability and commitment to returning capital to shareholders, supported by strong cash flow generation of 27.2 billion yen operating CF and robust financial position, though the elevated payout ratio relative to net income suggests reliance on cash generation rather than accounting profits for sustainability.
Dairy segment structural profitability with operating loss of -7.1 billion yen and margin of -10.7% including impairment charges of 3.3 billion yen represents the most critical business risk. The segment generated 66.4 billion yen revenue (18.3% of total) but destroyed value operationally, requiring urgent restructuring initiatives. Continuation of losses at this scale would materially impact consolidated profitability and may necessitate further asset write-downs or business model transformation. Operating margin compression to 2.4% from 3.3% YoY amid rising SG&A expenses presents sustainability concerns. SG&A ratio of 35.0% of revenue increased from prior levels, with advertising at 16.0 billion yen and salaries at 23.5 billion yen representing significant fixed cost burdens. Inability to leverage operating expenses or pass through cost increases to customers risks further margin deterioration. Gross margin compression to 37.4% as COGS growth of 8.8% outpaced revenue growth of 9.1% indicates pricing power limitations and input cost pressures, particularly in commodities such as dairy ingredients, sugar, and packaging materials. Foreign exchange volatility with FX losses of 0.8 billion yen in non-operating expenses and overseas revenue representing 25.1% of total exposes results to currency fluctuations, particularly yen-dollar and yen-yuan rates affecting the Overseas and China businesses.
[Industry Position] (Reference - Proprietary Analysis) The company's operating margin of 2.4% is positioned below food manufacturing industry standards, where median operating margins typically range 5-8% for diversified food manufacturers. Profitability metrics including ROE of -0.4% and net profit margin of -0.3% rank below industry median due to extraordinary charges and structural challenges in the Dairy segment. The equity ratio of 70.7% exceeds industry median of approximately 45-55%, indicating above-average financial stability and lower financial leverage compared to peers. Asset turnover of 0.92 times is consistent with capital-intensive food manufacturing operations, though opportunities exist to improve asset efficiency. The dividend payout ratio of 70.6% is elevated versus industry median of 30-40% for food manufacturers, suggesting aggressive shareholder return policy relative to earnings capacity. Cash flow generation capability with operating CF of 27.2 billion yen and operating CF margin of 7.5% demonstrates relative strength versus accounting profitability, indicating superior working capital management and non-cash charge impacts. The company's minimal leverage position with debt-to-equity of 0.001 versus industry median of 0.3-0.5 provides significant financial flexibility for restructuring investments or growth initiatives. Industry: Food Manufacturing (diversified confectionery, dairy, and processed foods), Comparison: Prior fiscal periods, Source: Proprietary analysis.
Revenue growth momentum of +9.1% demonstrates the company's ability to capture volume and pricing opportunities across domestic and overseas markets, with particularly strong performance in China (+21.1% YoY) and Dairy segment top-line (+18.5% YoY). The overseas segment achieving 25.1% revenue share with 9.1% operating margin represents a structural strength and growth platform, contrasting with challenged domestic profitability. Cash generation quality significantly exceeds reported earnings, with operating cash flow of 27.2 billion yen representing 7.5% of revenue and 1405.5% YoY growth, indicating underlying business cash economics remain sound despite accounting losses. This divergence between cash flow and reported earnings, driven by impairments and restructuring charges, suggests the market should focus on normalized earning power rather than GAAP net income. Structural reform imperative in Dairy segment with -7.1 billion yen operating loss requires management execution, but also represents potential earnings upside if successfully addressed, as returning this segment to breakeven would add approximately 7 billion yen to operating income. The company's fortress balance sheet with 70.7% equity ratio, 68.6 billion yen cash, and negligible debt provides substantial capacity to fund restructuring investments, pursue strategic M&A, or enhance shareholder returns, positioning it defensively while addressing operational challenges. Capital expenditure running at 0.52 times depreciation suggests potential underinvestment that could constrain future growth, warranting monitoring of management's capital allocation strategy and whether increased investment will be necessary to maintain competitive position and support overseas expansion.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.